Dennis Gartman, founder, editor & publisher of The Gartman Letter, comments on Monsanto's decision to reject the Bayer acquisition proposal.
Kirsty Wilson, senior analyst at Mergermarket, looks at the potential bidders for U.S. agrichemicals giant Monsanto, including potential interest from China.
Neil Dwane, global strategist at Allianz Global Investors, says many Bayer investors will view the deal negatively as they won't own Monsanto.
John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.
Just when you thought the dearth of M&A in Europe was here to stay, Bayer sweeps in with a $62 billion bid for U.S. giant Monsanto.
Werner Baumann, Bayer CEO, weighs in on the tax ramification of the combined companies.
Werner Baumann, Bayer CEO, explain why he went public with the $62 billion bid for Monsanto.
CNBC's Nancy Hulgrave reports on Bayer's big move to create a global leader in agriculture.
How tough will it be for Bayer, to convince investors that the Monsanto bid is worth it? Dealreporter assistant editor, Alex Tarrant weighs in.
Werner Baumann, Bayer CEO, explains why he thinks the company's offer for Monsanto would likely pass regulatory scrutiny and doesn't see risk in the deal.
The pharmaceutical company Bayer has announced plans to acquire American biotech company Monsanto, making an all cash offer of $122 per share.
Shares of Deere fell about 5 percent despite posting better-than-expected earnings.
CropX CEO Isaac Bentwich explains how he uses big data analytics and an IoT approach to determine where water is needed in the crop fields.
German drug and chemicals giant Bayer has made an unsolicited takeover offer for Monsanto, the world's biggest seed company.
Carl Tannenbaum, chief economist at Northern Trust, looks at the merger space with specific comment on the potential Bayer, Monsanto deal.
Even with some crop prices trending higher, the worst of the agricultural downturn may be far from over for Deere.
Legislation was introduced in the U.S. Senate and House on Wednesday to make food date labeling less confusing and more consistent.
Kashi is leading the way in promoting a new food label identifying farms transitioning from conventional to organic.
Genetically modified crops are safe for both human consumption and the environment, according to a report by top U.S. scientists on Tuesday.
Andersons on Wednesday rejected a $1 billion all-cash offer from HC2 Holdings, a company run by former hedge fund manager Philip Falcone.